Gene Green: “We should not continue to play politics with women's health.”

I hope we all agree on the importance of 340B and the need to stretch scarce federal resources as far as possible to reach more eligible patients and provide more comprehensive services.

The 340B Drug Pricing Program was created by Congress in 1992. It helps safety net providers care for their most vulnerable patients and afford drugs that would otherwise be out of reach.

Critically, MACRA encourages providers to move away from fee-for-service and participate in a new delivery model that will reduce costs while increasing quality.

Mr. Chairman, thank you for holding today's hearing on the Implementation of the 21st Century Cures Act.